Fig. 2
From: Kayadiol exerted anticancer effects through p53-mediated ferroptosis in NKTCL cells
Kayadiol-induced cell death form in NKTCL cells, A Intracellular ROS levels in YT cells treated with kayadiol (12.5 μM) for 24 h, * P < 0.05 vs control group. B Intracellular GSH levels in YT cells treated with kayadiol (12.5 μM) for 24 h, * P < 0.05 vs control group. C-E YT cells were treated with kayadiol (12.5 μM) with or without ROS scavenger NAC (5 mM), reduced GSH (1 mM), or ferroptosis inhibitor Fer-1 (1 μM) for 48 h, and cell viability was measured. The results are shown as the mean ± standard deviation, * P < 0.05